Open AccessIbrutinib Granted FDA ‘Breakthrough Therapy’ Designation for Two B-cell Malignancies
Author(s) -
AUTHOR_ID
Publication year - 2013
Publication title -
oncology times
Language(s) - English
Resource type - Journals
eISSN - 1548-4688
pISSN - 0276-2234
DOI - 10.1097/01.cot.0000428634.55584.c5
Subject(s) - ibrutinib , medicine , oncology , cancer research , leukemia , chronic lymphocytic leukemia